查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1672819

流感疫苗市場按疫苗類型、疫苗效力、接種途徑、年齡層、技術、分銷管道和地區分類

Influenza Vaccines Market, By Vaccine Type, By Valency, By Route of Administration, By Age Group, By Technology, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 197 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球流感疫苗市場規模估計為 89.1 億美元，預計到 2032 年將達到 145.9 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 7.3%。

報告範圍 報告詳細資訊
基準年 2024 2025 年市場規模 89.1億美元
效能資料 2020-2024 預測期 2025-2032
預測期：2025 年至 2032 年複合年成長率 7.30% 2032 年金額預測 145.9億美元
數字。 2025 年流感疫苗市場佔有率（按地區分類）
流感疫苗市場-IMG1

幾十年來，流感疫苗接種一直是預防性保健的重要組成部分。流感病毒經常發生變異和演化，因此每年都需要開發更新的疫苗。疫苗透過增強人體對變異病毒的免疫反應發揮作用。該疫苗旨在針對 3 至 4 種病毒株（取決於特定流感季節使用的疫苗類型）提供免疫力，這些病毒株是透過監測和其他科學研究確定的，在即將到來的流感季節最有可能在任何特定地區傳播。過去幾年，全球流感疫苗市場一直穩步成長，這得益於人們對季節性疫苗接種認知的不斷提高、新技術的採用、醫療機構的疫苗接種指南的不斷擴大以及世界各國政府的支持不斷增加。

市場動態

全球流感疫苗市場的成長受到多種因素的推動，例如流感疫情的加劇、國際衛生組織制定的疫苗接種指南的採用率不斷提高、疫苗接種意識的增強、新產品的推出、對重組疫苗的偏好增加以及主要企業的地理覆蓋範圍不斷擴大。然而，開發四價流感疫苗所涉及的高昂研發成本、新疫苗核准所需的嚴格監管準則以及由於流感病毒株抗原漂移而出現的疫苗抗藥性都是阻礙市場成長的一些障礙。市場相關人員在醫療基礎設施不斷改善、可支配收入不斷上升的新興經濟體中看到了機會。製造商也致力於開發一種能夠對多種流感病毒株提供持久保護的通用疫苗。

研究的主要特點

  • 本報告對全球流感疫苗市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%）。
  • 它還強調了各個領域的潛在商機並解釋了該市場的有吸引力的投資提案矩陣。
  • 它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
  • 它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，介紹了全球流感疫苗市場的主要企業概況。
  • 本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
  • 全球流感疫苗市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 透過全球流感疫苗市場分析中使用的各種策略矩陣，相關人員將更容易做出決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • 一致的機會圖 (COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 影響分析
  • 產業趨勢
  • 監管情景
  • 最近的產品核可/發布
  • PEST分析
  • 波特的分析

4. 全球流感疫苗市場-冠狀病毒 (COVID-19) 大流行的影響

  • 對需求的影響
  • 對醫療保健的影響
  • 流行病學

5. 2020 年至 2032 年全球流感疫苗市場（按疫苗類型分類）（十億美元）

  • 介紹
  • 惰性
  • 減毒活疫苗

6. 2020 年至 2032 年全球流感疫苗市值（單位：十億美元）

  • 介紹
  • 四價
  • 三價

7. 2020 年至 2032 年按給藥途徑分類的全球流感疫苗市場（十億美元）

  • 介紹
  • 注射
  • 鼻腔噴劑

8. 2020-2032 年全球流感疫苗市場（按年齡層分類）（十億美元）

  • 介紹
  • 孩子們
  • 成人

9. 2020 年至 2032 年全球流感疫苗市場（依技術分類）（十億美元）

  • 介紹
  • 雞蛋流感疫苗
  • 細胞培養流感疫苗
  • 重組流感疫苗

10. 2020-2032 年全球流感疫苗市場按分銷管道分類（十億美元）

  • 介紹
  • 公共
  • 私人的

第 11 章。 2020-2032 年全球流感疫苗市場（按地區分類）（十億美元）

  • 介紹
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲
  • 南非
  • 中部非洲
  • 北非

第12章 競爭格局

  • 熱圖分析
  • 市場佔有率分析
    • CSL Seqirus
    • GlaxoSmithKline plc
    • Sanofi
    • AstraZeneca
    • FluGen, Inc.
    • Moderna, Inc.
    • Biocryst Pharmaceuticals Inc.
    • CPL Biologicals Pvt. Ltd.
    • CureVac AG
    • OSIVAX
    • Solaris Vaccines
    • Pfizer
    • Daiichi Sankyo
    • Bharat BIoTech
    • Sinovac BIoTech
    • Solaris Vaccines

第 13 章 分析師觀點

  • 興衰
  • 一致的機會地圖

第 14 章 參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI1705

Global Influenza Vaccines Market is estimated to be valued at USD 8.91 Bn in 2025 and is expected to reach USD 14.59 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 8.91 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 7.30% 2032 Value Projection: USD 14.59 Bn
Figure. Influenza Vaccines Market Share (%), By Region 2025
Influenza Vaccines Market - IMG1

Influenza vaccines have been an important element of preventive healthcare for decades. The influenza viruses have the ability to mutate and evolve regularly, necessitating the development of updated vaccines each year. The vaccines work to boost the body's immune response to these changing viruses. They are designed to immunize against the three or four strains (depending on the vaccine type used for a particular flu season) that surveillance and other scientific studies have determined are most likely to be in circulation for the upcoming flu season in any given region. The global influenza vaccines market has witnessed steady growth over the past few years due to the growing awareness about seasonal vaccination, introduction of novel technologies, expansion of vaccination guidelines by healthcare organizations, and rising government support worldwide.

Market Dynamics:

The global influenza vaccines market growth is driven by various factors such as the increasing prevalence of influenza, growing adoption of vaccination guidelines set by international health organizations, rising awareness about vaccination, new product launches, growing preference for recombinant technology vaccines, and expansion in geographical reach of major players. However, the market growth can be challenging due to high R&D costs involved for development of quadrivalent influenza vaccines, stringent regulatory guidelines for approval of new vaccines and vaccine resistance arising due to antigenic drift of influenza virus strains. The market players see opportunities in emerging countries owing to improving healthcare infrastructure and rising disposable incomes. Manufacturers are also working on the development of universal influenza vaccine with durable protection against multiple flu strains.

Key Features of the Study:

  • This report provides an in-depth analysis of the global influenza vaccines market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global influenza vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study includes Seqirus, GlaxoSmithKline plc, Sanofi, AstraZeneca, FluGen Inc., Moderna Inc., Biocryst Pharmaceuticals Inc., CPL Biologicals Pvt. Ltd., CureVac AG, OSIVAX, Solaris Vaccines, Pfizer, CSL, Daiichi Sankyo, Bharat Biotech, and Sinovac Biotech.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global influenza vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global influenza vaccines market.

Market Segmentation

  • Vaccine Type:
    • Inactivated
    • Live Attenuated
  • Valency:
    • Quadrivalent
    • Trivalent
  • Route of Administration:
    • Injection
    • Nasal Spray
  • Age Group:
    • Pediatrics
    • Adults
  • Technology:
    • Egg-Based Flu Vaccines
    • Cell Culture-Based Flu Vaccines
    • Recombinant Flu Vaccines
  • Distribution Channel:
    • Public
    • Private
  • Regional:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Seqirus
    • GlaxoSmithKline plc
    • Sanofi
    • AstraZeneca
    • FluGen Inc.
    • Moderna Inc.
    • Biocryst Pharmaceuticals Inc.
    • CPL Biologicals Pvt. Ltd.
    • CureVac AG
    • OSIVAX
    • Solaris Vaccines
    • Pfizer
    • CSL
    • Daiichi Sankyo
    • Bharat Biotech
    • Sinovac Biotech

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Vaccine Type
    • Market Snapshot, By Valency
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Age Group
    • Market Snapshot, By Technology
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunity
  • Impact Analysis
  • Key Developments
  • Industry Trends
  • Regulatory Scenario
  • Recent Product Approval/Launches
  • PEST Analysis
  • Porter's Analysis

4. Global Influenza Vaccines Market- Impact of Coronavirus (COVID-19) Pandemic

  • Impact on Demand
  • Impact on Healthcare
  • Epidemiology

5. Global Influenza Vaccines Market, By Vaccine Type, 2020 - 2032, (USD BN)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Inactivated
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Live Attenuated
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)

6. Global Influenza Vaccines Market, By Valency, 2020 - 2032, (USD BN)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Quadrivalent
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Trivalent
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)

7. Global Influenza Vaccines Market, By Route of Administration, 2020 - 2032, (USD BN)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Injection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Nasal Spray
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)

8. Global Influenza Vaccines Market, By Age Group, 2020 - 2032, (USD BN)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Pediatrics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Adults
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)

9. Global Influenza Vaccines Market, By Technology, 2020 - 2032, (USD BN)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Egg-Based Flu Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Cell Culture-Based Flu Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Recombinant Flu Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)

10. Global Influenza Vaccines Market, By Distribution Channel, 2020 - 2032, (USD BN)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Public
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)
  • Private
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD BN)

11. Global Influenza Vaccines Market, By Region, 2020 - 2032 (USD BN)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032(%)
    • Y-o-Y Growth Analysis, For Regions, 2020 - 2032
    • Regional Trends
  • North America
    • Market Size and Forecast, By Vaccine Type, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Valency, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Age Group, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Technology, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Country, 2020 - 2032 (USD BN)
      • U.S.
      • Canada
  • Latin America
    • Market Size and Forecast, By Vaccine Type, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Valency, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Age Group, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Technology, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Country, 2020 - 2032 (USD BN)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Vaccine Type, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Valency, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Age Group, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Technology, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Country, 2020 - 2032 (USD BN)
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Vaccine Type, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Valency, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Age Group, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Technology, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Country, 2020 - 2032 (USD BN)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Vaccine Type, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Valency, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Age Group, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Technology, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Country, 2020 - 2032 (USD BN)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Vaccine Type, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Valency, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Age Group, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Technology, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032 (USD BN)
    • Market Size and Forecast, By Region/Country, 2020 - 2032 (USD BN)
  • South Africa
  • Central Africa
  • North Africa

12. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • CSL Seqirus
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • GlaxoSmithKline plc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Sanofi
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • AstraZeneca
    • FluGen, Inc.
    • Moderna, Inc.
    • Biocryst Pharmaceuticals Inc.
    • CPL Biologicals Pvt. Ltd.
    • CureVac AG
    • OSIVAX
    • Solaris Vaccines
    • Pfizer
    • Daiichi Sankyo
    • Bharat Biotech
    • Sinovac Biotech
    • Solaris Vaccines

13. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

14. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact